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2Abstract
Protein zero (P0), the major structural protein of peripheral nerve myelin, is a ~30 
kDa integral membrane glycoprotein consisting of an extracellular domain, a 
transmembrane domain, and a palmitoylated cytoplasmic domain. In native membranes 
of Xenopus laevis it exists primarily as a dimer. To determine the effects of glycosylation, 
acylation, and hydrophobic interactions on protein dimerization, I used SDS 
polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting, and high-
performance thin layer chromatography (HPTLC) to analyze the effects of 
deglycosylation, deacylation, and various detergent treatments on myelin isolated from 
Xenopus laevis sciatic nerve. These treatments showed no effect on P0 oligomerization, 
suggesting that glycosylation, acylation, and hydrophobic interactions disrupted by these 
detergents do not underlie P0 dimerization. The data points to the likelihood that covalent 
linkages contribute to P0  oligomerizaztion in Xenopus.
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4Table of Abbreviations
Abbreviation Full Name
OG N-octyl--D-glucopyranoside
CE Cholesterol ester
CH Hydroxy cerebrosides
CHAPSO 3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1- 
propanesulfonate
CN Non-hydroxy cerebrosides
CNS Central nervous system
CO Cholesterol
DG Diglyceride
DTT Dithiothreitol
ECL Enhanced chemiluminescent
EDTA Ethylenediaminetetraacetic acid
FA Fatty acid
GLC Gas-liquid chromatography
HA Hydroxylamine
HPTLC High-performance thin layer chromatography
MG Monoglyceride
P0 Protein zero
PAGE Polyacrylamide gel electrophoresis
PC Phosphatidylcholine
PE Phosphatidylethanolamine
PI Phosphatidylinositol
PLP Proteolipid protein
PNGase F Peptide N-glycosidase
PNS Peripheral nervous system
PS Phosphatidylserine
PVDF Polyvinylidene fluoride
SDS Sodium dodecyl sulfate
SH Hydroxy sulfatides
SM Sphingomyelin
SN Non-hydroxy sulfatides
TG Triglyceride
5Introduction
Myelin, which consists of a compact jelly-roll-like wrapping of lipid-rich 
membranes surrounding nerve axons, facilitates a much higher rate of nerve conduction 
between neurons than is possible in unmyelinated axons of the same diameter (Fig. 1). 
Myelin is produced by Schwann cells in the peripheral nervous system (PNS) and by 
oligodendroglial cells in the central nervous system (CNS);(Kirschner and Blaurock, 
1992). The most abundant component of myelin is lipid; however, proper membrane 
packing has been shown to be dependent upon the protein content of the membrane 
(Inouye and Kirschner, 1990).
Protein zero (P0), a ~30kDa integral membrane glycoprotein, is the most 
abundant protein and is the primary structural factor in peripheral nerve myelin 
(Kirschner et. al., 1996). The protein consists of a palmitoylated cytoplasmic domain, a 
transmembrane domain, and a glycosylated extracellular domain (Fig. 2). Mutations in P0 
lead to demyelination of peripheral nerves and underlie the clinical deficits in certain 
human peripheral neuropathies including Charcot-Marie-Tooth disease and Dejerine-
Sottas syndrome (Keller and Chance, 1999). The sequence of the protein is highly 
conserved in human, mouse, frog, and other species (Fig. 3). Analogous proteins 
discovered in peripheral nerve myelin of teleosts, including zebrafish, are called IP1 and 
IP2.
P0 exists primarily as a dimer in native membrane from amphibian (Xenopus), 
but not from higher vertebrates, and the level of oligomerization is apparently unaffected 
by changes in pH or salt concentration (Thompson, et. al., 2002). It is possible that 
posttranslational modifications of the protein are responsible for P0 oligomerization. P0 
6contains an N-linked carbohydrate on Asn93 in the extracellular domain of the protein 
and a palmitoylated cysteine in the cytoplasmic domain that may play a role in 
dimerization. Deacylation of proteolipid protein (PLP), a protein analogous to P0 in the 
central nervous system, by hydroxylamine (HA) has been shown to reduce the adhesive 
properties of the protein and leads to decompaction of CNS myelin as shown by electron 
microscopy (Bizzozero et. al., 2001). It is possible that HA treatment could have a similar 
effect on P0 and peripheral nerve myelin. 
It is also possible that hydrophobic interactions are responsible for P0 
dimerization. X-ray diffraction studies of whole Xenopus sciatic nerves treated with the 
zwitterionic detergent CHAPSO show symmetrization of membrane spacing (Z. 
Haddadin et. al., unpublished data), suggesting that membrane packing, and possibly P0 
oligomerization, has been disrupted. Palmitoylation of P0 could also contribute to 
hydrophobic interactions that stabilize P0 oligomers via a trans interaction of apposed P0 
molecules.
Myelin lipids from PNS and CNS myelin have been analyzed in mice using high-
performance thin layer chromatography (HPTLC) (Ganser et. al., 1988). The lipid 
content of Xenopus and zebrafish myelin is less understood, but can presumably be 
analyzed and compared to that of mouse myelin using the same methods. This method 
could also be used to verify the results of depalmitoylation of P0 with HA.
In this study, the factors influencing P0 oligomerization were examined using 
peripheral nerve myelin purified from Xenopus laevis. This organism was chosen for 
study because they are easily obtained and have large, well-developed sciatic nerves and 
a P0 sequence that is highly homologous to that of humans and mice. Also, the P0 in 
Xenopus peripheral nerve myelin exists primarily as a stable dimer that is easily 
7detectable in an SDS-PAGE gel and is absent in other species. Protein samples were 
separated and analyzed using SDS-PAGE and Western Blotting, and lipid samples were 
separated and analyzed using HPTLC, for the speed and specificity of analysis that these 
procedures allow. Using these procedures also allowed comparison with previously 
obtained data from Xenopus and mouse PNS myelin studies using similar methods. In 
many cases, samples of isolated PNS myelin from Xenopus were compared to samples of 
PNS and CNS myelin from mouse or zebrafish treated in parallel.
By subjecting the isolated myelin to several different biochemical treatments, we 
hoped to disrupt the Xenopus P0 dimer and elucidate what causes its unusual stability.  
The long-range goal of this research is to understand what underlies P0 protein-protein 
interactions in Xenopus peripheral nerve myelin, and thereby explain how PNS myelin 
protein stabilizes myelin structure. 
8Materials and Methods
Sample selection and preparation:
Sciatic nerves were isolated from adult female Xenopus laevis (Xenopus I, Inc., 
Dexter, MI) and sciatic nerves, brains, and optic nerves were isolated from adult female 
B6 mice (courtesy of Dr. T. Seyfried, Boston College) and homogenized in water with 
aprotinin (1µg/mL) to prevent proteolysis. Myelin was isolated using a discontinuous 
sucrose gradient (Norton and Poduslo, 1973).  Lateral line and optic nerves were isolated 
from adult zebrafish and myelin was isolated using a modified discontinuous sucrose 
gradient protocol in which a lower volume of nerve homogenate and fewer washes 
maximized the yield.
Sample treatment:
Isolated myelin was treated with N-glycosidase F (PNGase F); (Sigma-Aldrich, 
Inc., St. Louis, MO), an enzyme that cleaves N-linked carbohydrates from denatured 
proteins, in order to remove the N-linked carbohydrate from P0. The protein was first 
denatured in .2%SDS and 1% -mercaptoethanol at 100°C for 3 minutes, then sample 
buffer was added to a final concentration of 0.15% SDS, 0.75% -mercaptoethanol, 
100mM Na2HPO4, 25mM EDTA, and 1% Triton X-100. Enzyme was then added and the 
solution was incubated overnight (~16h) at 37°C. Enzyme activity was stopped by 
boiling in SDS-PAGE sample buffer. Isolated myelin was also treated with 0mM-667mM 
9hydroxylamine (HA) solution for 1 hr. at 30°C, and with 5,10, and 25mM CHAPSO 
(Sigma-Aldrich, Inc., St. Louis, MO) and N-octyl--D-glucopyranoside (OG); (AG 
Scientific, Inc., San Diego, CA) for 1hr. at 37°C. 
Protein visualization and analysis:
Treated and untreated myelin samples were separated using SDS-PAGE alongside 
broad-range molecular standards (BioRad, Inc., Hercules, CA). Samples were heated to 
100°C in sample buffer (2% SDS, 10% glycerol, 0.1mM DTT, 0.01% bromophenol blue, 
0.063M Tris-Cl) before loading. Gels were 8cm 4-20% Tris-HCl Novex precast 
polyacrylamide minigels (Invitrogen Inc., Carlsbad, CA), run at a constant voltage of 
125V for approximately 90 minutes, until the dye front reached the end of the gel. Gels 
were stained using standard Coomassie blue protocol, stained using the Silver Stain Plus 
Kit (BioRad Inc., Hercules, CA), or blotted onto PVDF membrane (Millipore, Inc., 
Bedford, MA) using the Mini-trans Blot tank apparatus (BioRad Inc., Hercules, CA) at 
35V for 2h. Western blotting was carried out with the ECL Western Blotting Analysis 
System (Amersham Biosciences, Inc., Piscataway, NJ). Primary P0 antibodies were 
monoclonal mouse IgG obtained from the laboratory of Dr. Richard Quarles. 
Glycoprotein detection was carried out after blotting on PVDF membrane using the ECL 
Glycoprotein Detection Module (Amersham Biosciences, Inc., Piscataway, NJ). Gels and 
film were scanned, and gels were dried in 5% glycerol solution between cellophane 
sheets.
Lipid analysis:
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After treatment of isolated myelin with HA, its lipid content was analyzed using 
one-dimensional HPTLC.  Each 50µL myelin sample contained either 1M or 0M HA 
solution, and was incubated for 45min at 30°C. The samples were then diluted with 
ddH20 to 200µL and extracted with two washes of 200µL of pure chloroform. The 
chloroform was then evaporated under a steam of nitrogen gas and the contents 
resuspended in 100µL of chloroform. Aliquots of 15 µL of these samples were hand 
spotted onto a 10x10cm silica gel HPTLC plate (Whatman Inc., Clinton, NJ) along with a 
lipid standard mix (Nu-Chek Prep, Inc., Elysian, MN) and palmitic acid standard (Sigma-
Aldrich, Inc., St. Louis, MO). 
Neutral lipid standards include cholesterol ester (CE; cholesteryl oleate), 
triglyceride (TG; tristearin), diglyceride (DG; distearin), cholesterol (CO), free fatty acid 
(FA; stearic), and monoglyceride (MG; 1-monostearyl). Polar lipid standards include 
non-hydroxy and hydroxy cerebrosides (CN, CH), non-hydroxy and hydroxy sulfatides 
(SN, SH), ethanolamine phosphatides (PE), phosphatidic acid (PI), phosphatidylserine 
(PS), phosphatidylcholine (PC), and sphingomyelin (SM);(Nu-Chek Prep, Inc., Elysian, 
MN). 
Polar lipids were separated with a mixture of methyl acetate/1-
propanol/chloroform/methanol/.25% KCl/acetic acid (25:25:25:10/9/.3). Neutral lipids 
were separated with first with a mixture of chloroform/methanol/acetic acid (93.1:1.9:.1) 
to 1.5cm from the top of the plate, then redeveloped with a mixture of hexane/ethyl 
ether/acetic acid (89.3:5.7:.1) to the top of the plate. Color was developed by charring the 
plates at 140°C after immersing the plate in aqueous 10% CuSO4•5H2O, 8% H3PO4 
solution (Ganser et. al., 1988). Plates were then scanned and the digital chromatograms 
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were analyzed. 
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Results
Deacylation of P0 with HA
Treatment with HA showed no effect on the level of Xenopus P0 oligomerization 
in small concentrations (0-500mM) when compared to P0 from untreated myelin. In 
higher concentrations (>500mM), HA caused aggregation of the samples, preventing 
them from running properly on the gel (Fig. 4). After treatment of isolated myelin with 
225mM HA, there was no difference in the oligomerization of P0 from either Xenopus or 
mouse (Fig. 5). HPTLC analysis of lipids from HA treated and untreated Xenopus myelin 
samples showed no significant increase in the level of free palmitic acid in the treated 
samples (Fig. 6). Samples of HA treated isolated myelin from mouse CNS and PNS did 
not show an increase in the level of free palmitic acid when compared to untreated 
samples (Fig. 7,8). 
Deglycosylation of P0 with PNGase F
Deglycosylation of P0 from Xenopus and mouse showed no effect on P0 
oligomerization. A band-shift representing the size of the removed carbohydrate moiety 
is observed, as well as an additional ~36kDa band which has been identified as the 
PNGase F enzyme (Fig. 9). Deglycosylation was confirmed by using the ECL 
glycoprotein detection kit on Western blots of treated and untreated myelin samples. 
Color developed in lanes with untreated samples of Xenopus and mouse myelin but did 
not develop in lanes with PNGase F treated samples (Fig. 10).
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Detergent treatments:
Treatment of Xenopus myelin with 5-25mM CHAPSO and OG also did not 
affect the level of P0 oligomerization (Fig. 11). Treatment of isolated myelin with 25 or 
100mM HA as described above followed by treatment with 25mM CHAPSO showed no 
effect on the level of P0 oligomerization (Fig. 12)
Lipid analysis
The polar and neutral lipid content of Xenopus PNS myelin, both untreated and 
treated with HA, has been successfully visualized using HPTLC (Figs. 5,13). No 
significant increase in the level of free palmitic acid was visible in the HA treated sample 
when compared with the untreated sample. Lipids from mouse CNS and PNS myelin, 
untreated and treated with HA, have also been visualized using this method for 
comparison (Figs. 7,8,14,15). In these samples, there no significant increase in the level 
of free palmitic acid in the HA treated samples when compared with the untreated 
samples. 
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Discussion
Amphibian peripheral nerve myelin P0 forms stable dimers in native membrane 
that are unaffected by changes in pH and ionic strength (Thompson et. al., 2002). To test 
the possibility that hydrophobic forces, glycosylation, or palmitoylation underlie the 
stability of the P0 dimer, isolated PNS myelin from Xenopus was subjected to several 
biochemical treatments and the protein and lipid content was analyzed using SDS-PAGE 
and HPTLC. 
Treatment of Xenopus myelin with HA and PNGase F reproducibly showed no 
change in the level of P0 oligomerization. These results suggest that palmitoylation and 
glycosylation of P0 do not play a role in oligomerization of the protein. The 
deglycosylation of P0 by this method was confirmed using glycoprotein specific 
detection, and the identities of the bands were confirmed by Western Blotting with anti-
P0 antibody.  Deacylation of P0 by treatment with HA was not confirmed by our HPTLC 
lipid analysis of isolated Xenopus myelin. Deacylation of myelin proteins in mouse 
isolated CNS and PNS myelin also was not apparent using this method.  However, there 
is an apparent increase in the concentration of lipids from HA treated myelin samples. 
This may be due to more efficient extraction of lipids from HA treated myelin, although 
the exact cause is unclear. The lack of increase in free palmitic acid as visualized using 
HPTLC may be the result of a low relative amount of cleaved palmitic acid in the 
samples. The increase in free palmitic acid may not be significant in either mouse or 
Xenopus when compared to the high levels of other lipids in the sample. Deacylation of 
PLP from isolated mouse CNS myelin by HA under the same conditions was confirmed 
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by Bizzozero (2001) using gas-liquid chromatography (GLC) to monitor the level of 
covalently bound fatty acids on isolated PLP.  This method is sensitive only to palmitic 
acid bound to protein, and could be used to show decreasing levels of bound fatty acid on 
isolated P0 as a more sensitive and selective means of confirming palmitic acid cleavage. 
Treatment of isolated Xenopus myelin with CHAPSO or OG did not affect the 
level of P0 oligomerization. Treatment with CHAPSO following HA treatment also 
appeared to have no effect. Although this data suggests that palmitoylation does not play 
a role in hydrophobic interactions that may stabilize the P0 dimer, it does not eliminate 
the possibility that hydrophobic interactions are responsible for P0 oligomerization. It is 
possible, although unlikely, that another detergent treatment or different incubation 
conditions would disrupt the P0 dimer. 
Future plans for this project include combining the results of this research on 
isolated myelin with X-ray diffraction studies of whole Xenopus sciatic nerves to 
determine how protein-protein interactions in Xenopus PNS myelin, specifically the P0 
dimer, are related to membrane packing. Also, as the forces that stabilize the P0 dimer 
have not yet been elucidated, research in this area should continue. Other detergent 
treatments or incubation conditions could be explored as a means to disrupting P0 
oligomerization in isolated myelin from Xenopus to conclusively determine if this 
interaction is stabilized by hydrophobic interactions. 
The possibility that another type of covalent linkage, possibly an Arg-Lys 
crosslink (formed by the sugar-catalyzed Maillard reaction);(Dyer 29), stabilizes the 
dimer should also be explored. The nature of the bond stabilizing the P0 dimer could be 
explored by isolation of the dimer from an SDS-PAGE gel followed by digestion of the 
protein with proteases. The fragments could then be separated on a preparative gel and 
16
analyzed using mass spectrometry. By comparing these fragments with the results of an 
identical enzymatic treatment of known monomer, the protein fragment that contains the 
crosslink could be identified and the nature of the crosslink elucidated. 
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Figures
Figure 1. Organization of the myelin sheath surrounding an axon. A. Superstructure of 
the myelin sheath. B. Repeating lipid bilayers making up the myelin sheath. C. Cross-
section through lipid membrane (Schmitt, 1950).
Figure 2. Schematic representation of PNS myelin protein orientation. Branches show 
carbohydrate chains. (Kirschner and Blaurock, 1992).
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Figure 3. Sequence alignment of P0 protein from several species.
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Figure 4. SDS-PAGE gel. Lanes 1,8 broad-range standard, lanes 2-7 isolated myelin 
from Xenopus treated with 0, 0.167, 0.5, 0.83, 1.33, and 1.67M HA.
Figure 5. SDS-PAGE gel. Lane 1 broad-range standard, lanes 3,5 untreated myelin from 
Xenopus and mouse, lanes 4,6 myelin from Xenopus and mouse after 225mM HA 
treatment for 1hr. at 37°C.
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Figure 6. HPTLC plate, neutral lipids. Lane 1 neutral lipid standards, lane 2 palmitic
acid, lanes 3,4 lipids isolated from untreated and HA treated isolated PNS myelin from 
Xenopus.
Figure 7. HPTLC plate, neutral lipids. Lane 1 neutral lipid standards, lane 2 palmitic 
acid, lanes 3,4 lipids isolated from untreated and HA treated isolated PNS myelin from 
mouse.
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Figure 8. HPTLC plate, neutral lipids. Lane 1 neutral lipid standards, lane 2 palmitic 
acid, lanes 3,4 lipids isolated from untreated and HA treated isolated CNS myelin from 
mouse.
Figure 9. SDS-PAGE gel. Lanes 1,6 broad-range standard, lanes 2,3 PNS myelin isolated 
from Xenopus untreated and after PNGase F treatment, lanes 4,5 PNS myelin isolated 
from mouse untreated and after PNGaseF treatment.
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Figure 10. X-ray film from ECL glycoprotein detection. Lanes 2,4 isolated PNS myelin 
from Xenopus and mouse, lanes 1,3 isolated PNS myelin from Xenopus and mouse after 
PNGase F treatment (no color development).
Figure 11. SDS-PAGE gel. Lanes 1,12 broad-range standard, lane 2 PNS myelin isolated 
from Xenopus lanes 3,4,5 PNS myelin isolated from Xenopus treated with 5,10, and 
25mM CHAPSO, lanes 6,7,8 PNS myelin isolated from Xenopus treated with 5,10, and 
25mM OG. 
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Figure 12. SDS-PAGE gel. Lanes 1,8 broad-range standard, lane 2 untreated PNS myelin 
isolated from Xenopus, lane 3 25mM HA treated PNS myelin from Xenpus, lane 4 
10mM CHAPSO treated PNS myelin from Xenopus, lane 5 25mM HA and 10mM 
CHAPSO treated PNS myelin from Xenopus.
Figure 13. HPTLC plate, polar lipids. Lane 1 polar lipid standards, lane 2 palmitic acid, 
lanes 3,4 lipids isolated from untreated and HA treated isolated PNS myelin from 
Xenopus.
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Figure 14. HPTLC plate, polar lipids. Lane 1 polar lipid standards, lane 2 palmitic acid, 
lanes 3,4 lipids isolated from untreated and HA treated isolated PNS myelin from mouse.
Figure 15. HPTLC plate, polar lipids. Lane 1 polar lipid standards, lane 2 palmitic acid, 
lanes 3,4 lipids isolated from untreated and HA treated isolated CNS myelin from mouse.
